Towards Healthcare
Biodefense Market Size to Capture USD 32.87 Billion by 2034

Biodefense Market Strategic Developments and Opportunities Report

Projections indicate that, the global biodefense market will increase from USD 16.81 billion in 2024 to USD 32.87 billion by 2034, experiencing a CAGR of 6.95% over the next 10 years. The rising prevalence of infectious disorders and the increasing threat of bioterrorism drive the market. Technological advancements and favorable government support contribute to North America’s dominance.

Content

  • Insight Code: 5796
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The biodefense market is projected to reach USD 32.87 billion by 2034, growing at a CAGR of 6.95% from 2025 to 2034.

North America is leading the biodefense market due to the availability of state-of-the-art research and development facilities, favorable government support, and technological advancements.

The biodefense market includes 4 segments including by product type, by technology, by application, and by region.

Some key players include Acurx Pharmaceuticals, Inc., Emergent BioSolutions, and Ichor Medical Systems, Inc.

Key trends include the increasing development of novel therapeutics, the rising prevalence of infectious disorders, and government initiatives.

Biodefense incorporates various activities, such as bio-surveillance, counterterrorism, biological arms control and nonproliferation, biosafety and biosecurity, and medical planning and preparedness.

Anthrax, botulinum toxin, and plague are some of the common examples of biological threats.

Administration for Strategic Preparedness & Response, World Health Organization, Centers for Disease Control and Prevention, Food and Drug Administration
Any Questions